Oral Biologics & Biosimilars Market: Unprecedented Growth with CAGR of 23.5%, Key Drivers and Emerging Trends

"
Rapid growth in the Oral Biologics & Biosimilars Market is primarily driven by increased demand due to a cost-effective manufacturing process, rise in the prevalence of chronic diseases, and robust research and development activities.

What Is The Projected Market Size Of The Global Oral Biologics & Biosimilars Market And Its Growth Rate?
The Oral Biologics & Biosimilars Market growth rates suggest a highly promising future:
- The market was worth $7.04 billion in 2024 and is projected to reach $8.69 billion in 2025 at a CAGR of 23.5%.
- The market size is forecasted to reach $19.13 billion in 2029 at a CAGR of 21.8%.

What Is Driving The Growth In The Oral Biologics & Biosimilars Market?
The rise in chronic diseases, including arthritis, asthma, and cancer, is a key growth driver for the oral biologics and biosimilar market. Lifestyle factors such as long working hours, limited physical activity, and unhealthy diet habits contribute to the prevalence of these diseases. The United Nations predicts that chronic diseases will account for 70% of all fatalities worldwide by 2030. As a result, the rising prevalence of chronic conditions is fueling the growth of the biologics and biosimilar market.

Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=6830&type=smp

Who Are the Key Players Driving Oral Biologics & Biosimilars Market Growth?
The market growth is powered by major players that include:

- Merck & Co. Inc.
- GlaxoSmithKline
- Novo Nordisk
- ALK-Abelló
- Aimmune Therapeutics Inc.
- VIVUS Inc
- Materia Medica Holding
- VECTOR-MEDICA
- Henlius
- Innovent Biologics
- Bio-Thera
- Hisun Pharma
- 3SBio
- Beijing ShuangLu Pharmaceuticals
- Qilu Pharmaceutical
- Shanghai Fosun Pharmaceuticals
- Biocon
- Dr.Reddy's
- Mylan
- Kyowa Hakko Kirin
- Takeda
- Mitsubishi Tanabe
- AGC Biologics
- BiosanaPharma
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Sanofi
- Microgen
- Geropharm
- Valenta
- NovaMedica
- SynBio
- Roche
- Rani Therapeutics
- Eli Lilly and Company
- Emisphere Technologies Inc.
- Enteris BioPharma
- Allena Pharmaceuticals
- Abbvie
- Johnson & Johnson
- Pfizer Inc.
- Biogen Inc.
- Aché
- Eurofarma
- Teva Pharmaceuticals
- Oramed Pharmaceuticals
- Entera Bio
- Julphar
- Hikma Pharmaceuticals
- Altis Biologics
- Cipla Medpro South Africa
- Genzyme

What Are The Key Trends In The Oral Biologics & Biosimilars Market?
Key trends in the market include:
- Investing in the oral biologics market for potentially strong profit margins.
- Shifting to biologics as the innovation rate is increasing in that field.
- Developing microneedle injectors-based drugs to increase bioavailability and eliminate side effects of the subcutaneous route.

What Are The Segments Of The Global Oral Biologics & Biosimilars Market?
The Oral Biologics & Biosimilars Market is categorized into segments:
- By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors, Immunostimulants, GPCR Modulators, Other Therapies.
- By Disease: Diabetes, Arthritis and Crohn's Disease, Cancer, Infectious Disease, Other Autoimmune Diseases, Other Diseases.
- By Molecule Type: Vaccines, Proteins and Peptides, Monoclonal Antibodies, Other Molecule Types.
- By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Which Region Leads The Oral Biologics & Biosimilars Market?
North America was the largest region in the oral biologics and biosimilar drugs market in 2024, while the Middle East is expected to be the fastest-growing region over the forecast period. Other regions in the market report are Asia-Pacific, Western Europe, Eastern Europe, South America, and Africa.

Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

What Is Covered In The Oral Biologics & Biosimilars Market Global Market Report?

- Market Size Analysis: Analyze the Oral Biologics & Biosimilars Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Oral Biologics & Biosimilars Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Oral Biologics & Biosimilars Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Oral Biologics & Biosimilars Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report: https://www.thebusinessresearchcompany.com/customise?id=6830&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company
The Business Research Company offers comprehensive, data-rich research and insights. With over 15,000+ reports from 27 industries covering 60+ geographies and armed with 1,500,000 datasets, it thrives on in-depth secondary research and unique insights from industry leaders for informed decision-making. The Global Market Model (GMM) remains its premier market intelligence platform delivering comprehensive and updated forecasts."

This release was published on openPR.